Barentz Acquires Anshul Life Sciences in India

Barentz International, a leading global provider of specialty ingredient solutions, announces the acquisition of Anshul Life Sciences Group in India, a premium life sciences focused specialty chemicals distributor serving the regulated pharmaceutical, food and nutraceutical, and personal care markets. With this strategic move, Barentz establishes a leading life sciences distribution platform in India and strengthens its commitment to providing innovative solutions, technical expertise, and a more innovative range of ingredients to customers and constituents across India.

The acquisition underscores Barentz’s commitment to the Indian market and is expected to open up strategic growth opportunities in India and across the Asia Pacific region. Both companies are committed to ensuring a seamless transition and maintaining the highest standards of value-added services.

The acquisition will further strengthen Barentz’s position in India, creating a leading life sciences distribution platform. Anshul Life Sciences strengthens and complements Barentz India’s pharmaceutical ingredients portfolio with high-quality excipients, APIs, and intermediates, and expands its personal care and nutraceutical product range. The merger will unlock significant growth potential in the Asia Pacific region.

Nagarajan Kailasam (CEO) and the current team of Anshul Life Sciences will continue to manage the day-to-day business operations.